An 80/20% training/testing split (balanced by mRS score) was created
In occlusion/occlusion-like syndromes affecting both periphery and brain (portal hypertension, caval hypertension, intracranial hypertension), BPC-157 simultaneously normalized blood pressure disturbances, healed gastrointestinal and liver lesions, minimized brain lesions and hemorrhage, prevented thrombosis, and preserved neurological function
Disadvantages: shorter shelf life from date of compounding, you cannot choose your concentration, typically more expensive per milligram
Not only are we conveniently located near Houston, but we also are one of the first IV therapy businesses in our neighborhood
Zerbinati C, Caponecchia L, Rago R, et al